生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | The bromodomain and PHD finger-containing (BRPF) family of BRPF1 is essential for the assembly of MYST histone acetyltransferase complexes. GSK6853 is a potent, selective, soluble, and cell-active inhibitor of the BRPF1 bromodomain (TR-FRET pIC50=8.1; NanoFRET pIC50=7.7). In the BROMOscan panel of bromodomain binding assay, GSK6853 exhibited potent inhibition towards BRPF1 with a pKd value of 9.5 and >1600-fold selectivity over other bromodomains. In male CD1 mice, GSK6853 showed a high blood clearance (107mL/min/kg), a moderate volume of distribution (5.5L/kg) and a moderate terminal half-life (1.7h) following intravenous injection (1mg/kg). Via oral administration (3 mg/kg), GSK6853 demonstrated a moderate systemic exposure (Cmax=42ng/mL; Tmax=1.5h) and a bioavailability of 22%. Intraperitoneal administration (3 mg/kg) achieved a Cmax of 469ng/mL, Tmax of 0.25h, and a bioavailability of 85%[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.44mL 0.49mL 0.24mL |
12.21mL 2.44mL 1.22mL |
24.42mL 4.88mL 2.44mL |
参考文献 |
---|